1. Home
  2. ZYXI vs BNR Comparison

ZYXI vs BNR Comparison

Compare ZYXI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • BNR
  • Stock Information
  • Founded
  • ZYXI 1996
  • BNR 2014
  • Country
  • ZYXI United States
  • BNR China
  • Employees
  • ZYXI N/A
  • BNR N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BNR Medical Specialities
  • Sector
  • ZYXI Health Care
  • BNR Health Care
  • Exchange
  • ZYXI Nasdaq
  • BNR Nasdaq
  • Market Cap
  • ZYXI 44.8M
  • BNR 38.3M
  • IPO Year
  • ZYXI N/A
  • BNR 2020
  • Fundamental
  • Price
  • ZYXI $1.50
  • BNR $8.27
  • Analyst Decision
  • ZYXI Hold
  • BNR
  • Analyst Count
  • ZYXI 3
  • BNR 0
  • Target Price
  • ZYXI $3.00
  • BNR N/A
  • AVG Volume (30 Days)
  • ZYXI 103.1K
  • BNR 38.7K
  • Earning Date
  • ZYXI 10-23-2025
  • BNR 09-08-2025
  • Dividend Yield
  • ZYXI N/A
  • BNR N/A
  • EPS Growth
  • ZYXI N/A
  • BNR N/A
  • EPS
  • ZYXI N/A
  • BNR N/A
  • Revenue
  • ZYXI $144,808,000.00
  • BNR $74,862,782.00
  • Revenue This Year
  • ZYXI N/A
  • BNR $136.32
  • Revenue Next Year
  • ZYXI $7.07
  • BNR N/A
  • P/E Ratio
  • ZYXI N/A
  • BNR N/A
  • Revenue Growth
  • ZYXI N/A
  • BNR 5.20
  • 52 Week Low
  • ZYXI $1.23
  • BNR $2.18
  • 52 Week High
  • ZYXI $9.42
  • BNR $11.12
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 42.77
  • BNR 51.01
  • Support Level
  • ZYXI $1.44
  • BNR $8.30
  • Resistance Level
  • ZYXI $1.55
  • BNR $9.55
  • Average True Range (ATR)
  • ZYXI 0.09
  • BNR 0.70
  • MACD
  • ZYXI 0.02
  • BNR -0.15
  • Stochastic Oscillator
  • ZYXI 29.03
  • BNR 24.68

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: